Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

GW Albers, P Amarenco, JD Easton, RL Sacco, P Teal - Chest, 2004 - Elsevier
This chapter about treatment and prevention of stroke is part of the 7th ACCP Conference on
Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines. Grade 1 …

Systematic review of methods for assessing leptomeningeal collateral flow

F McVerry, DS Liebeskind… - American journal of …, 2012 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The importance of LMF in the outcome after acute
ischemic stroke is increasingly recognized, but imaging presents a wide range of options for …

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke

RT Higashida, AJ Furlan - stroke, 2003 - Am Heart Assoc
Background and Purpose—The National Institutes of Health (NIH) estimates that stroke
costs now exceed $45 billion per year. Stroke is the third leading cause of death and one of …

Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial

A Furlan, R Higashida, L Wechsler, M Gent, H Rowley… - Jama, 1999 - jamanetwork.com
ContextIntravenous tissue-type plasminogen activator can be beneficial to some patients
when given within 3 hours of stroke onset, but many patients present later after stroke onset …

Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?

C Berger, M Fiorelli, T Steiner, WR Schäbitz… - Stroke, 2001 - Am Heart Assoc
Background and Purpose—The term symptomatic hemorrhage secondary to ischemic stroke
implies a clear causal relationship between clinical deterioration and hemorrhagic …

Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke

JK Lynch, DG Hirtz, G DeVeber, KB Nelson - Pediatrics, 2002 - publications.aap.org
The National Institute of Neurological Disorders and Stroke and the Office of Rare Disorders
sponsored a workshop on perinatal and childhood stroke in Bethesda, Maryland, on …

Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention …

A Ogawa, E Mori, K Minematsu, W Taki, A Takahashi… - Stroke, 2007 - Am Heart Assoc
Background and Purpose—The Middle Cerebral Artery Embolism Local Fibrinolytic
Intervention Trial (MELT) Japan was organized to determine the safety and clinical efficacy …

Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment

J Montaner, J Alvarez-Sabín, C Molina, A Anglés… - Stroke, 2001 - Am Heart Assoc
Background and Purpose—Uncontrolled expression of matrix metalloproteinases (MMPs)
can result in tissue injury and inflammation. In animal models of cerebral ischemia, the …

Assessment of≥ 50% and< 50% intracranial stenoses by transcranial color-coded duplex sonography

RW Baumgartner, HP Mattle, G Schroth - Stroke, 1999 - Am Heart Assoc
Background and Purpose—A favorable risk-benefit ratio for warfarin compared with aspirin
has been reported for the prevention of major vascular events in symptomatic≥ 50 …

Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines

GW Albers, P Amarenco, JD Easton, RL Sacco, P Teal - Chest, 2008 - Elsevier
This article about treatment and prevention of stroke is part of the Antithrombotic and
Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical …